Expression of CD34 in hematopoietic cancer cell lines reflects tightly regulated stem/progenitor-like state

Journal of Cellular Biochemistry

Volumn 112, Issue 5, 2011, Pages 1277-1285

  Kuranda, Klaudia ^a,b   Berthon, Céline ^a,b,c   Leprêtre, Frédéric ^d,e   Polakowska, Renata ^a   Jouy, Nathalie ^d   Quesnel, Bruno ^a,b,c  

^a INSERM   (France)

^b Institut de Recherche sur le Cancer de Lille   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d UNIV LILLE   (France)

^e Institut Fédératif de Recherche 114   (France)

Author keywords

cancer stem cells; CD34 protein; hematopoiesis; progenitors; thymopoietin

Indexed keywords

CYTOKINE; METHYLCELLULOSE; THYMOPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER STEM CELL; CD34 SELECTION; CELL CONTACT; CELL DIVISION; CELL SELECTION; CELL SEPARATION; CELL STRAIN HL 60; CELL STRAIN U266; CELL SUBPOPULATION; COLONY FORMING CELL; CONTROLLED STUDY; CYTOKINE RELEASE; FLUORESCENCE ACTIVATED CELL SORTING; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC CELL; HUMAN; IMMUNOPHENOTYPING; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; STEM CELL;

MUS;

EID: 79953707918     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23026     Document Type: Article

References (28)

1. Bhatia M, Bonnet D, Murdoch B, Gan OI, Dick JE,. 1998. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat Med 4: 1038-1045. (Pubitemid 28417336)
2. Bonnet D, Dick JE,. 1997. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3: 730-737. (Pubitemid 27298715)
3. Botturi M, Panzarasa R, Agostara B, Armaroli L, Belli M, Barone D, Boccone F, Busutti L, Catalano E, Ciambellotti E,. 1993. Effects of immunomodulation on antineoplastic radiotherapy. A controlled clinical study. Radiol Med 86: 327-335.
4. Cascinelli N, Belli F, Mascheroni L, Lenisa L, Clemente C,. 1998. Evaluation of clinical efficacy and tolerability of intravenous high dose thymopentin in advanced melanoma patients. Melanoma Res 8: 83-89. (Pubitemid 28114307)
5. Cheshier SH, Prohaska SS, Weissman IL,. 2007. The effect of bleeding on hematopoietic stem cell cycling and self-renewal. Stem Cells Dev 16: 707-717. (Pubitemid 350125226)
6. Dao MA, Arevalo J, Nolta JA,. 2003. Reversibility of CD34 expression on human hematopoietic stem cells that retain the capacity for secondary reconstitution. Blood 101: 112-118. (Pubitemid 36025896)
7. Dooley DC, Oppenlander BK,. 2004. Phenotypic and functional analyses of CD34NEG hematopoietic precursors from mobilized peripheral blood. Methods Mol Biol 263: 201-218.
8. Dou J, Wen P, Hu W, Li Y, Wu Y, Liu C, Zhao F, Hu K, Wang J, Jiang C, He X, Gu N,. 2009. Identifying tumor stem-like cells in mouse melanoma cell lines by analyzing the characteristics of side population cells. Cell Biol Int 33: 807-815.
9. Fillmore CM, Kuperwasser C,. 2008. Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res 10: R25.
10. Goldstein G, Scheid MP, Boyse EA, Schlesinger DH, Van Wauwe J,. 1979. A synthetic pentapeptide with biological activity characteristic of the thymic hormone thymopoietin. Science 204: 1309-1310. (Pubitemid 9223717)
11. Harper LJ, Piper K, Common J, Fortune F, Mackenzie IC,. 2007. Stem cell patterns in cell lines derived from head and neck squamous cell carcinoma. J Oral Pathol Med 36: 594-603. (Pubitemid 47609813)
12. Kondo T,. 2007. Stem cell-like cancer cells in cancer cell lines. Cancer Biomark 3: 245-250. (Pubitemid 351492648)
13. Kondo T, Setoguchi T, Taga T,. 2004. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci USA 101: 781-786. (Pubitemid 38121035)
14. Krause DS, Fackler MJ, Civin CI, May WS,. 1996. D34: Structure, biology, and clinical utility. Blood 87: 1-13. (Pubitemid 26018389)
15. Kuranda K, Berthon C, Dupont C, Wolowiec D, Leleu X, Polakowska R, Jouy N, Quesnel B,. 2010. A subpopulation of malignant CD34+CD138+B7-H1+ plasma cells is present in multiple myeloma patients. Exp Hematol 38: 124-131.
16. Latagliata R, Petti MC, Aloe Spiriti MA, Tirindelli MC, Fazi P, De Gregoris C, Mandelli F,. 1991. Thymopentin in the treatment of myelodysplastic syndromes. Acta Haematol 86: 115.
17. Lepretre F, Villenet C, Quief S, Nibourel O, Jacquemin C, Troussard X, Jardin F, Gibson F, Kerckaert JP, Roumier C, Figeac M,. 2010. Waved aCGH: To smooth or not to smooth. Nucleic Acids Res 38: e94.
18. Murase M, Kano M, Tsukahara T, Takahashi A, Torigoe T, Kawaguchi S, Kimura S, Wada T, Uchihashi Y, Kondo T, Yamashita T, Sato N,. 2009. Side population cells have the characteristics of cancer stem-like cells/cancer-initiating cells in bone sarcomas. Br J Cancer 101: 1425-1432.
19. Nakamura Y, Ando K, Chargui J, Kawada H, Sato T, Tsuji T, Hotta T, Kato S,. 1999. Ex vivo generation of CD34(+) cells from CD34(-) hematopoietic cells. Blood 94: 4053-4059.
20. Osawa M, Hanada K, Hamada H, Nakauchi H,. 1996. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 273: 242-245. (Pubitemid 26285891)
21. Sato T, Laver JH, Ogawa M,. 1999. Reversible expression of CD34 by murine hematopoietic stem cells. Blood 94: 2548-2554. (Pubitemid 29477281)
22. Singh VK, Biswas S, Mathur KB, Haq W, Garg SK, Agarwal SS,. 1998. Thymopentin and splenopentin as immunomodulators. Current status. Immunol Res 17: 345-368. (Pubitemid 28302191)
23. Solmajer T,. 1990. Design of a novel thymopoietin analogue based on conformational analyses. Drug Des Deliv 6: 213-221. (Pubitemid 20302004)
24. Sundal E, Bertelletti D,. 1994. Thymopentin treatment of rheumatoid arthritis. Arzneimittelforschung 44: 1145-1149.
25. Sutherland HJ, Blair A, Zapf RW,. 1996. Characterization of a hierarchy in human acute myeloid leukemia progenitor cells. Blood 87: 4754-4761. (Pubitemid 26162376)
26. Trinci M, Belli G, Santarelli M, Raffetto N, Trinci M,. 1995. Evaluation of the treatment with thymopentin associated with radiotherapy in head and neck tumors. Clin Ter 146: 457-467. (Pubitemid 26083203)
27. Wang J, Kimura T, Asada R, Harada S, Yokota S, Kawamoto Y, Fujimura Y, Tsuji T, Ikehara S, Sonoda Y,. 2003. SCID-repopulating cell activity of human cord blood-derived. Blood 101: 2924-2931.
28. Zanjani ED, Almeida-Porada G, Livingston AG, Flake AW, Ogawa M,. 1998. Human bone marrow. Exp Hematol 26: 353-360.